JP2011525181A5 - - Google Patents

Download PDF

Info

Publication number
JP2011525181A5
JP2011525181A5 JP2011514778A JP2011514778A JP2011525181A5 JP 2011525181 A5 JP2011525181 A5 JP 2011525181A5 JP 2011514778 A JP2011514778 A JP 2011514778A JP 2011514778 A JP2011514778 A JP 2011514778A JP 2011525181 A5 JP2011525181 A5 JP 2011525181A5
Authority
JP
Japan
Prior art keywords
polypeptide
peptide
cholesterol efflux
isolated polypeptide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011514778A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011525181A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/047694 external-priority patent/WO2009155366A2/en
Publication of JP2011525181A publication Critical patent/JP2011525181A/ja
Publication of JP2011525181A5 publication Critical patent/JP2011525181A5/ja
Withdrawn legal-status Critical Current

Links

JP2011514778A 2008-06-18 2009-06-17 コレステロール流出の改良型ペプチドメディエータ Withdrawn JP2011525181A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7370808P 2008-06-18 2008-06-18
US61/073,708 2008-06-18
PCT/US2009/047694 WO2009155366A2 (en) 2008-06-18 2009-06-17 Improved peptide mediators of cholesterol efflux

Publications (2)

Publication Number Publication Date
JP2011525181A JP2011525181A (ja) 2011-09-15
JP2011525181A5 true JP2011525181A5 (cg-RX-API-DMAC10.html) 2011-10-27

Family

ID=41434685

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011514778A Withdrawn JP2011525181A (ja) 2008-06-18 2009-06-17 コレステロール流出の改良型ペプチドメディエータ

Country Status (14)

Country Link
US (1) US8415293B2 (cg-RX-API-DMAC10.html)
EP (1) EP2300038A4 (cg-RX-API-DMAC10.html)
JP (1) JP2011525181A (cg-RX-API-DMAC10.html)
KR (1) KR20110043597A (cg-RX-API-DMAC10.html)
CN (1) CN102123722A (cg-RX-API-DMAC10.html)
AU (1) AU2009260024A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0915422A2 (cg-RX-API-DMAC10.html)
CA (1) CA2727465A1 (cg-RX-API-DMAC10.html)
CL (1) CL2010001445A1 (cg-RX-API-DMAC10.html)
IL (1) IL209868A0 (cg-RX-API-DMAC10.html)
MX (1) MX2010014003A (cg-RX-API-DMAC10.html)
PE (1) PE20110106A1 (cg-RX-API-DMAC10.html)
RU (1) RU2011101536A (cg-RX-API-DMAC10.html)
WO (1) WO2009155366A2 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130123173A1 (en) * 2010-04-28 2013-05-16 The Regents Of The University Of California Creation of oxidation-resistant hdl mimetic peptides
US10017551B2 (en) 2013-03-15 2018-07-10 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
RU2016144908A (ru) 2014-05-02 2018-06-05 Серени Терапеутикс Холдинг Са Маркеры hdl-терапии
WO2016044177A1 (en) * 2014-09-17 2016-03-24 The Regents Of The University Of California Peptides having reduced toxicity that stimulate cholesterol efflux
US10532105B2 (en) * 2015-07-10 2020-01-14 Peptinovo Biopharma, LLC. Formulations for improving the efficacy of hydrophobic drugs
US11840707B2 (en) 2016-05-31 2023-12-12 Institut De Cardiologie De Montreal Co-culture system and method for in vitro assessment of reverse cholesterol transport
CN110294791B (zh) * 2019-06-13 2023-02-21 倪京满 具有胆固醇外流活性的抗动脉粥样硬化肽类似物及其应用
CN111848742B (zh) * 2020-07-23 2021-03-23 南京医科大学 一种多肽及其制药用途
CN112511569B (zh) * 2021-02-07 2021-05-11 杭州筋斗腾云科技有限公司 网络资源访问请求的处理方法、系统及计算机设备
CN115300609B (zh) * 2021-05-08 2026-07-28 西湖大学 缺氧诱导脂滴相关蛋白(hilpda)在预防或治疗高血脂相关疾病中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1706131A4 (en) 2003-12-15 2009-08-12 Univ California THE CELLULAR CHOLESTEROL EFFLUX STIMULATING HELICULAR SYNTHETIC PEPTIDES
ATE533783T1 (de) 2006-12-13 2011-12-15 Univ California Potente und selektive mittlersubstanzen von cholesterolefflux

Similar Documents

Publication Publication Date Title
JP7009559B2 (ja) リポタンパク質複合体ならびにその製造および使用
US20160137711A1 (en) Glucagon-like peptide-2 compositions and methods of making and using same
TW434260B (en) New variants of apolipoprotein A-I
UA71554C2 (en) Agonists of apolipoprotein a-i and their use for treatment of disorders associated with dyslipidemia
UA71553C2 (uk) АГОНІСТ АПОЛІПОПРОТЕЇНУ А-І (ApoA-I), МУЛЬТИМІРНИЙ ApoA-I (ВАРІАНТИ), КОМПЛЕКС АГОНІСТА ApoA-I І ЛІПІДУ ТА СПОСІБ ЛІКУВАННЯ ДИСЛІПІДЕМІЧНИХ ПОРУШЕНЬ
TW201215394A (en) Tetranectin-apolipoprotein A-I, lipid particles containing it and its use
RU2011101536A (ru) Усовершенствованные пептидные медиаторы оттока холестерина
CN101524529A (zh) HNF4α诱导分化治疗人体恶性实体瘤
JP2010513311A5 (cg-RX-API-DMAC10.html)
KR20240153552A (ko) 치료용 사이토카인 및 방법
CN1312178C (zh) 高密度脂蛋白反应性肽
CN110606895A (zh) 人重组甲硫氨酸亚砜还原酶a蛋白的结构和构建方法
US20080193947A1 (en) Complementary Peptides For Beta-Amyloid 29-42 Peptide
CN117384269A (zh) 短肽mfrlp及其在制备动脉重塑相关疾病药物中的应用
HK40113633A (en) Lipoprotein complexes and manufacturing and uses thereof
CN108342405A (zh) Il21融合蛋白及其制备方法和在制备靶向治疗肿瘤药物中的用途
Laccotripe Structural and functional analysis of human apolipoprotein AI
WO2011139819A2 (en) Creation of oxidation-resistant hdl mimetic peptides
Sheluho Probing the mechanism of proteins that mediate assembly of the mitochondrial ATP synthase
HK1198834B (en) Lipoprotein complexes and manufacturing and uses therof
HK1192266B (en) Lipoprotein complexes and manufacturing and uses thereof